MedPath

Sewon Cellontech Co., Ltd.

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

The Post-marketing Surveillance to Evaluate the Efficacy of CHONDRON (Autologous Cultured Chondrocyte) by Arthroscopy

Phase 4
Conditions
Traumatic Arthritis
Osteoarthritis
First Posted Date
2015-09-02
Last Posted Date
2015-09-02
Lead Sponsor
Sewon Cellontech Co., Ltd.
Target Recruit Count
10
Registration Number
NCT02539069
Locations
🇰🇷

Yonsei University Severance Hospital, Seoul, Korea, Republic of

Comparison of Efficacy and Safety of Microfracture and Modified Microfracture

Phase 4
Conditions
Traumatic Arthritis
Defect of Articular Cartilage
Osteoarthritis
First Posted Date
2015-09-02
Last Posted Date
2015-09-02
Lead Sponsor
Sewon Cellontech Co., Ltd.
Target Recruit Count
100
Registration Number
NCT02539030
Locations
🇰🇷

The Catholic University of Korea Bucheon St. Mary's Hospital, Bucheon, Gyeonggi, Korea, Republic of

🇰🇷

The Catholic University of Korea Vincent's Hospital, Suwon, Gyeonggi, Korea, Republic of

🇰🇷

Wonkwang University Hospital, Iksan, Jeollabuk-do, Korea, Republic of

and more 9 locations

Efficacy of Intra-articular Collagen Injection in Patients With Knee Joint Pain Compared to Normal Saline Injection

Phase 4
Conditions
Traumatic Arthritis
Chondromalacia
Osteoarthritis
First Posted Date
2015-09-02
Last Posted Date
2015-09-02
Lead Sponsor
Sewon Cellontech Co., Ltd.
Target Recruit Count
200
Registration Number
NCT02539095
Locations
🇰🇷

Chung-Ang University Hospital, Seoul, Korea, Republic of

🇰🇷

Kunkuk University Medical Center, Seoul, Korea, Republic of

🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

and more 2 locations

the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis

Phase 4
Conditions
Plantar Fasciitis
Interventions
Drug: normal saline
Device: Regenseal
First Posted Date
2015-09-02
Last Posted Date
2015-09-02
Lead Sponsor
Sewon Cellontech Co., Ltd.
Target Recruit Count
60
Registration Number
NCT02539082
Locations
🇰🇷

Daejeon Sun Hospital, Daejeon, Korea, Republic of

🇰🇷

Eulji General Hospital, Seoul, Korea, Republic of

🇰🇷

Inje University Seoul Paik Hospital, Seoul, Korea, Republic of

The Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte)

Phase 4
Conditions
Osteoarthritis
Traumatic Arthritis
First Posted Date
2015-09-02
Last Posted Date
2015-09-02
Lead Sponsor
Sewon Cellontech Co., Ltd.
Target Recruit Count
24
Registration Number
NCT02539056
Locations
🇰🇷

Inha Univerisity Hospital, Incheon, Korea, Republic of

🇰🇷

Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of

Efficacy and Safety of Chondron (Autologus Chondrocyte) in Patients With Cartilage Defects in Their Ankle

Phase 3
Conditions
Ankle (Ligaments); Instability, Familial
Defect of Articular Cartilage
Degenerative Joint Disease of Ankle and/or Foot
Interventions
Drug: CHONDRON
First Posted Date
2015-09-01
Last Posted Date
2015-09-01
Lead Sponsor
Sewon Cellontech Co., Ltd.
Target Recruit Count
28
Registration Number
NCT02537067
Locations
🇰🇷

Myongji Hospital, Goyang, Gyeonggi, Korea, Republic of

🇰🇷

Eulji General Hospital, Seoul, Korea, Republic of

the Safety and Efficacy Evaluation of Chondron Compared With Mircrofracture of Knee

Conditions
Defect of Articular Cartilage
Degeneration; Articular Cartilage, Knee
Articular Cartilage Disorder of Knee
First Posted Date
2015-08-14
Last Posted Date
2015-08-31
Lead Sponsor
Sewon Cellontech Co., Ltd.
Target Recruit Count
50
Registration Number
NCT02524509
Locations
🇰🇷

Inha University Medical School Hospital, Incheon, Inchoen, Korea, Republic of

the Efficacy and Safety of a Modified Microfracture Using Collagen Compared to Those of a Simple Microfracture in Ankle

Phase 4
Conditions
Defect of Articular Cartilage
First Posted Date
2015-08-11
Last Posted Date
2015-08-11
Lead Sponsor
Sewon Cellontech Co., Ltd.
Target Recruit Count
60
Registration Number
NCT02519881
Locations
🇰🇷

Soon Chun Hyang University Hospital Bucheon, Bucheon, Gyeonggi-do, Korea, Republic of

🇰🇷

Eulji general Hospital, Seoul, Korea, Republic of

🇰🇷

Hallym University Medical Center-Kangnam Sacred Heart Hospital, Seoul, Korea, Republic of

Efficacy and Safety of SurgiFill™ on Spinal Fusion

Phase 4
Conditions
Fusion of Spine (Disease)
Spinal Fusion Acquired
First Posted Date
2015-06-09
Last Posted Date
2015-06-09
Lead Sponsor
Sewon Cellontech Co., Ltd.
Target Recruit Count
20
Registration Number
NCT02466048
Locations
🇰🇷

The Catholic Univ. of Korea, Daejeon St. Mary's Hospital, Daejeon, Korea, Republic of

🇰🇷

The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of

An Efficacy and Safety Study of TheraFill® Versus KOKEN for 3 Months on Nasolabial Folds

Phase 3
Completed
Conditions
Nasolabial Folds
First Posted Date
2010-02-02
Last Posted Date
2010-02-02
Lead Sponsor
Sewon Cellontech Co., Ltd.
Target Recruit Count
73
Registration Number
NCT01060943
Locations
🇰🇷

Kangnam St.Mary's Hospital of Catholic University, Seoul, Seo-cho, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath